Ballok, Melham T.
HRN: 26-05-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/16/2024
10/22/2024
IVT
4.5g
Q6
ARF Sec To Pulmonary Tuberculosis Bacteriologically Confirmed On Top Of CAP HR, In Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes